Did you know the eye contains 60 times more vitamin C than your blood? In fact, your eyes contain the highest concentration of vitamin C in your entire body. Vitamin C is a powerful antioxidant and it protects the cells in your eyes from damage.
In a study at Oregon Health & Science University published in the Journal of Neuroscience, Henrique von Gersdorff, Ph.D., says, “We found that cells in the retina need to be ‘bathed’ in relatively high doses of vitamin C, inside and out, to function properly.”
Vitamin C has been showed to protect against, or slow the progress of, the following conditions:
- Age-related macular degeneration
The American Optometric Society says, “Numerous studies have linked vitamin C intake and ocular health. A study demonstrated that women using vitamin C for 10 years or more experienced a 64 percent reduction in the risk of developing nuclear cataracts… Other research showed that women taking a daily supplementation dosage of 364 mg experienced a 57 percent reduction in their risk of certain types of cataracts.”
The University of Maryland Medical Center recommends AREDS (The Age-Related Eye Disease Study) formula to help slow the progression of macular degeneration. The AREDS formula includes vitamin C, vitamin E, beta-carotene, and zinc, plus copper (vitamin C being the largest dose).
Worldwide, more than 25 million people are affected by age-related macular degeneration (AMD) and the formation of cataracts, especially people over 55. Vitamin C can help slow the damage or even prevent it. Progressive’s Vitamin C Complex contains 600 mg per capsule as well as a host of support nutrients to increase bioavailability and absorption. It contains no added flavours, colours, sweeteners or artificial preservatives of any kind. Keep your eyes healthy.
This is a guest blog post from Progressive Nutritional Therapies
PubMed.gov: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.